Mr. Gill is currently the CFO of EndoChoice, a medical device company which provides devices, diagnostics, infection control and imaging for specialists treating a wide range of gastrointestinal diseases. Prior to joining EndoChoice, he served as CFO of INC Research, a clinical research organization.
Histogenics is a regenerative medicine company focused on developing and commercializing products in the musculoskeletal market.
More articles on devices:
Spine device company stock report — 5 key companies
Smith & Nephew’s 2014 revenue up 2%: 10 things to know
8 key points on Misonix’s 2Q financial report — sales up 36%
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
